MetaCap

Scribe Therapeutics Statistics

NASDAQ: SCTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

12.07-1.15 (-8.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Scribe Therapeutics by the numbers

Scribe Therapeutics has a market capitalization of $228.6 million based on 18.94M shares outstanding. With trailing EPS of $-6.35, Scribe Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 38.3% below its 50-day average and 46.0% below its 200-day average.

Average daily trading volume is 403.27K shares, or about $4.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SCTX valuation vs. peer median

SCTX compared with the median of 8 peer companies
MetricSCTXPeer medianDifference
Market cap$228.58M$243.09M-6%
Avg. volume403.27K2.02M-80%

Peer median across 8 companies: ALLO, AUTL, PLX, LXEO, IPSC, EDIT, SABS, CABA.

Valuation

Price and trading

Previous close
13.22
Open
12.87
Day range
12.00 – 13.40
52-week range
12.00 – 39.60
Beta
—
Volume
301.40K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
228.58M
Forward Pe
-3.56
Eps
-6.35
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
39.60
Week52 Low
12.00
Avg Volume
403.27K
Shares Outstanding
18.94M
Ma50
19.56
Ma200
22.35
Earnings Date
Dec 2, 2026
Pct From52w High
-69.52%
Pct From52w Low
0.58%

Related